Search Results - "Maree, A. O."

QT prolongation in non-telemetered hospitalized elderly patients by Bajrangee, A., Mahabir, S., Khalifa, W., Maree, A.O., McAdam, B.

“…Bajrangee et al discuss their study on QT prolongation in non-telemetered hospitalized elderly patients. They recruited consecutive patients who presented to…”
Get full text

Cyclooxygenase‐1 haplotype modulates platelet response to aspirin by MAREE, A. O., CURTIN, R. J., CHUBB, A., DOLAN, C., COX, D., O'BRIEN, J., CREAN, P., SHIELDS, D. C., FITZGERALD, D. J.

“…Background: Aspirin (acetylsalicylic acid) irreversibly inhibits platelet cyclooxygenase (COX)‐1, the enzyme that converts arachidonic acid (AA) to the potent…”
Get full text

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT) by Meliga, E, Garcia-Garcia, H.M, Valgimigli, M, Chieffo, A, Biondi-Zoccai, G, Maree, A.O, Gonzalo, N, Cook, S, Marra, S, Moretti, C, De Servi, S, Palacios, I.F, Windecker, S, van Domburg, R, Colombo, A, Sheiban, I, Serruys, P.W

“…Abstract Aim To compare the long-term relative efficacy and safety of SES and PES in patients undergoing percutaneous coronary intervention (PCI) for…”
Get full text

Cost burden of non-specific chest pain admissions by Groarke, J., O’Brien, J., Go, G., Susanto, M., Owens, P., Maree, A. O.

“…Background Non-cardiac aetiologies are common among patients presenting with chest pain. Aim To determine the cost of non-specific chest pain admissions to a…”
Get full text

Early and mid-term outcomes after transcatheter aortic valve implantation (TAVI) in Ireland by Bajrangee, A., Coughlan, J.J., Teehan, S., O'Connor, C., Murphy, R.T., Foley, B., Daly, C., Burke, D., Maree, A.O., Crean, P.A.

“…TAVI is a percutaneous approach to aortic valve replacement in high surgical risk patients deemed inoperable. To evaluate the early and mid-term outcomes for…”
Get full text

G-protein beta 3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trial by Maree, A O, VANGJELI, C, JNEID, H, Ryan, J, Cox, D, Cannon, C P, Shields, D C, Fitzgerald, D J

“…Background: Variability in platelet response to antiplatelet drugs is heritable. A common single base substitution (825C>T) in the G-protein beta polypeptide 3…”
Get full text

Non-coronary sinus of Valsalva aneurysm rupture by Maree, A O, Liberthson, R R, Fifer, M A

“…Careful examination of the cinematographic images indicated that the shunt flow entered the right atrium and hit the closed tricuspid valve leaflets in systole…”
Get full text

Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry by Rodriguez, Alfredo E., Maree, Andrew O., Mieres, Juan, Berrocal, Daniel, Grinfeld, Liliana, Fernandez-Pereira, Carlos, Curotto, Valeria, Rodriguez-Granillo, Alfredo, O'Neill, William, Palacios, Igor F.

“…Aims Long-term benefit from coronary revascularization with drug-eluting stents (DES) relative to bare metal stents (BMS) and coronary artery bypass grafting…”
Get full text

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease by MAREE, Andrew O, FITZGERALD, Desmond J

Get full text

G‐protein β3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes–thrombolysis in myocardial infarction 16 trial by MAREE, A. O., VANGJELI, C., JNEID, H., RYAN, J., COX, D., CANNON, C. P., SHIELDS, D. C., FITZGERALD, D. J.

“…Background: Variability in platelet response to antiplatelet drugs is heritable. A common single base substitution (825C>T) in the G‐protein beta polypeptide 3…”
Get full text

Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease by Maree, Andrew O., Curtin, Ronan J., Dooley, Michelle, Conroy, Ronan M., Crean, Peter, Cox, Dermot, Fitzgerald, Desmond J.

“…We investigated whether use of low-dose enteric-coated (EC) aspirin for secondary prevention of cardiovascular events has sufficient bioavailability to achieve…”
Get full text

Non-coronary sinus of Valsalva aneurysm rupture by Maree, A O, Liberthson, R R, Fifer, M A

“…Careful examination of the cinematographic images indicated that the shunt flow entered the right atrium and hit the closed tricuspid valve leaflets in systole…”
Get full text

G-protein beta3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trial by Maree, A O, Vangjeli, C, Jneid, H, Ryan, J, Cox, D, Cannon, C P, Shields, D C, Fitzgerald, D J

“…Variability in platelet response to antiplatelet drugs is heritable. A common single base substitution (825C>T) in the G-protein beta polypeptide 3 (GNB3) gene…”
Get full text

Aspirin and coronary artery disease by Maree, Andrew O, Fitzgerald, Desmond J

“…Coronary atherosclerosis (CAD), a chronic inflammatory disorder, arises when genetic susceptibility, intercurrent conditions such as diabetes and hypertension…”
Get more information

P594Contrast transthoracic echocardiography as a gatekeeper for patent foramen ovale closureP595Mitral annular displacement in apical four-chamber view by speckle-tracking echocardiography as a simple index for left ventricular longitudinal systolic functionP596Impact of chronic glycemic control on left ventricular myocardial function in young patients with type 1 diabetes mellitusP597Association of left atrial function echocardiographic parametres with fibrosis assesed invasively in patients wi by Muratori, M., Hozumi, T., Ruisanchez Villar, C., Pilichowska, E., Chebrolu, L., Stefani, L., Akcakoyun, M., Keski-Pukkila, KT, Li, W-H, Khalil, W., Bajrangee, A., Sciatti, E., Nemes, A., Selim, EHAB, Italiano, G., Innocenti, E., Fusini, L., Mapelli, M., Tamborini, G., Ghulam Ali, S., Gripari, P., Maltagliati, A., Celeste, F., Pepi, M., Emori, H., Takemoto, K., Terada, K., Orii, M., Ohkochi, K., Kameyama, T., Ozaki, Y., Kuroi, A., Tanimoto, T., Matsuo, Y., Ino, Y., Kubo, T., Tanaka, A., Akasaka, T., Gonzalez Vilchez, FJ, Piedra Leon, M., Marigomez Estrada, M., Pesquera Gonzalez, C., Ruano Calvo, J., Zarauza Navarro, J., Martin Duran, R., Amado Senaris, JA, Baran, J., Kulakowski, P., Zaborska, B., Schutt, R., Maragiannis, D., Abudiab, M., Sunkara, A., Alvarez, P., Nagueh, S., Zoghbi, WA, Pedrizzetti, GP, Tosi, BT, Pedri, SP, Galanti, GG, Eren, H., Avci, A., Demir, S., Evlice, M., Guner, A., Tabakci, M., Toprak, C., Inanir, M., Kargin, R., Tuohinen, S., Skytta, T., Huhtala, H., Virtanen, V., Kellokumpu-Lehtinen, P-L, Raatikainen, P., Nikus, K., Liu, Y., Tsai, W-C, Mahabir, S., King, G., Cuddy, S., Feigherty, C., Maree, AO, Conlon, N., Murphy, RT, Vizzardi, E., Bonadei, I., Platto, F., Metra, M., Foldeak, D., Domsik, P., Kalapos, A., Borbenyi, Z., Sepp, R., Forster, T., El Tahan, SALAH, Loutfi, M., El Sharkawy, EMAN

Get full text

Percutaneous closure of a post-infarction ventricular septal defect that recurred after surgical repair by Maree, Andrew O, Jneid, Hani, Palacios, Igor F

Get full text

Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: A guide for pharmacists and other health care professionals : Expert opinion from the american heart association's diagnostic and interventional catheterization committee and council on clinical cardiology, and the American College of Clinical Pharmacy's Cardiology Practice Research Network by LEVINE, Glenn N, BERGER, Peter B, COHEN, David J, MAREE, Andrew O, ROSENFIELD, Kenneth, WIGGINS, Barbara S, SPINIER, Sarah A

“…Significant advances in pharmacotherapy for patients undergoing percutaneous coronary intervention (PCI) have occurred during the past decade, including the…”
Get full text

Thrombosis and nitric oxide donor drugs by Maree, Andrew O, Cox, Dermot

Get more information